Cvs Health Corporation · NYSE:CVS
Cvs Health — Investor Day (December 2021)
12 slides from Cvs Health's investor day presentation, Dec 9, 2021
Slide 1: Driving sustainable growth in PSS through customer focus and innovation
2021 2021 INVESTOR INVESTOR DAY DAY Driving sustainable growth in PSS through customer focus and innovation ALAN LOTVIN, M.D. Executive Vice President and President, Pharmacy Services
Slide 2: Cautionary statement concerning forward-looking statements
These presentations include forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. The statements made in the presentations today and the information that is included in th
Slide 3: Pharmacy Services Segment: PBM leadership
Pharmacy Services Segment Our PBM leadership with consumers, employers, health plans and government entities #1 Leader ~80% 2.9% Ranked Across customer Captured of known Overall drug trend by PBM consultants1 segments2 new business revenue in 2020 Fortune 100, health plans, that moved with 2022 Mana
Slide 4: Our business today, positioned for growth
Pharmacy Services Segment Our business today, positioned for growth… $151.0B – $153.2B +10% $8.9B FY 2021E Total Revenues Grow above industry and lean in to shift towards Specialty & new value streams Adjusted operating income Net new business in 2017 – 2021E CAGR 2022 selling season3 $6.85B – $6.94
Slide 5: Sustainable PSS growth is achieved through…
Pharmacy Services Segment Sustainable PSS growth is achieved through… 1 2 3 Leading with capabilities Focusing on highest Enhancing and service growth markets profitability Deliver industry-leading Capture Specialty Pharmacy Enhance digital self-serve tools drug trend growth, including growing speci
Slide 6: We win and retain business by delivering best-in-class service
Pharmacy Services Segment 1 We win and retain business by delivering best-in-class service across all key capabilities How that translates to 3.9% 5.8% Trend management Q3 YTD 2021 overall drug trend Q3 YTD 2021 Specialty drug trend growth Competitive offering to drive Trust, 99% 91% strong retentio
Slide 7: We focus on highest-growth markets, including Specialty
Pharmacy Services Segment 2 We focus on highest-growth markets, including Specialty, to drive greatest value Specialty accounts for over half of pharmacy spend12.... How that translates to Within this significant market, CVS Specialty Rx9 11% CVS Specialty Rx 9% Specialty Rx growth is outpacing the
Slide 8: Opportunity growing as era of generics and biosimilars in Specialty arrives
Pharmacy Services Segment 2 …and the opportunity is growing as the era of generics and biosimilars in Specialty is arriving Top specialty branded products with generic/biosimilar competition How that translates to (U.S. market sales, illustrative not exhaustive)13 growth ~$50B E.g. Keytruda Enbrel 2
Slide 9: We continue to enhance our business to deliver value to clients and shareholders
Pharmacy Services Segment 3 We continue to enhance our business to deliver meaningful value to clients and shareholders How that translates to Continue Improve digital self-serve consumer focus experience growth Enable Rx Accelerate adoption of generic Results in better pricing competition and biosi
Slide 10: PSS accelerates growth of CVS Health
Pharmacy Services Segment PSS accelerates growth of CVS Health… • Commercialize health services via Caremark’s sales channel How will PSS accelerate • Connect our pharmacy capabilities to provide choice to consumers enterprise growth? • Grow integrated medical / pharmacy lives with HCB …and CVS Heal
Slide 11: In closing… Key takeaways
Pharmacy Services Segment • Leading manager of pharmacy spend for our customers • PSS both enables growth of and benefits from the growth of an expanded set of In closing… health services Key takeaways • Experienced and stable management team capitalizing on opportunities • Market-leading PBM and Sp
Slide 12: Endnotes
Pharmacy Services Segment Endnotes All data is provided by CVS Health Enterprise Analytics or other internal CVS Health Sources, unless otherwise noted. All data is as of September 30, 2021, unless otherwise noted. 1. Annual PBM Selling Season Checks Most Positive on CVS Caremark (Mizhuho), July 2,